Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 332

1.

Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.

Zhang PP, Sun JW, Wang XY, Liu XM, Li K.

Eur J Surg Oncol. 2013 Sep;39(9):951-6. doi: 10.1016/j.ejso.2013.06.008. Epub 2013 Jun 28.

PMID:
23810331
2.

Preoperative plasma D-dimer predicts 1-year survival in colorectal cancer patients with absence of venous thromboembolism (VTE): a prospective clinical cohort study.

Stender MT, Larsen TB, Sørensen HT, Thorlacius-Ussing O.

J Thromb Haemost. 2012 Oct;10(10):2027-31. doi: 10.1111/j.1538-7836.2012.04887.x.

3.

[Pre-operative plasma D-dimer level may predict the poor prognosis within one year after the surgery for non-small cell lung cancer].

Wang Z, Fu J, Diao D, Dang C.

Zhongguo Fei Ai Za Zhi. 2011 Jun;14(6):534-7. doi: 10.3779/j.issn.1009-3419.2011.06.10. Chinese.

4.

Prognostic significance of plasma D-dimer levels in patients with lung cancer.

Taguchi O, Gabazza EC, Yasui H, Kobayashi T, Yoshida M, Kobayashi H.

Thorax. 1997 Jun;52(6):563-5.

5.

Prognostic value of plasma D-dimer levels in lung carcinoma.

Komurcuoglu B, Ulusoy S, Gayaf M, Guler A, Ozden E.

Tumori. 2011 Nov-Dec;97(6):743-8. doi: 10.1700/1018.11091.

6.

High plasma D-dimer level is associated with decreased survival in patients with lung cancer.

Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, Tabakoglu E, Hatipoglu ON, Caglar T.

Clin Oncol (R Coll Radiol). 2007 Sep;19(7):494-8. Epub 2007 May 21.

PMID:
17513096
7.

Imbalance between vascular endothelial growth factor and endostatin correlates with the prognosis of operable non-small cell lung cancer.

Hu Y, Hu MM, Shi GL, Han Y, Li BL.

Eur J Surg Oncol. 2014 Sep;40(9):1136-42. doi: 10.1016/j.ejso.2014.05.014. Epub 2014 Jun 26.

8.

D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.

Ay C, Vormittag R, Dunkler D, Simanek R, Chiriac AL, Drach J, Quehenberger P, Wagner O, Zielinski C, Pabinger I.

J Clin Oncol. 2009 Sep 1;27(25):4124-9. doi: 10.1200/JCO.2008.21.7752. Epub 2009 Jul 27.

PMID:
19636003
9.

Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease.

Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N.

Ann Thorac Surg. 2004 Jul;78(1):216-21.

PMID:
15223432
10.

Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.

Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, Shiomi K, Saito Y.

Ann Thorac Surg. 2006 Jan;81(1):292-7.

PMID:
16368383
12.

Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.

Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, Mandai K, Eguchi K.

Anticancer Res. 2000 May-Jun;20(3B):2177-80.

PMID:
10928173
13.

Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.

Ferroni P, Martini F, Portarena I, Massimiani G, Riondino S, La Farina F, Mariotti S, Guadagni F, Roselli M.

Clin Lung Cancer. 2012 Nov;13(6):482-7. doi: 10.1016/j.cllc.2012.03.005. Epub 2012 May 15.

PMID:
22591606
14.

Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer.

Firat S, Bousamra M, Gore E, Byhardt RW.

Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):1047-57.

PMID:
11958901
15.

Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.

Kasprzyk M, Dyszkiewicz W, Piwkowski C, Brudlo M, Galecki B, Gabryel P, Gasiorowski L.

Neoplasma. 2013;60(1):62-7. doi: 10.4149/neo_2013_009.

PMID:
23067218
16.

[Factors predictive of survival after lobectomy for non-small cell lung cancer in Iceland during 1999-2008].

Oskarsdóttir GN, Skúladóttir R, Isaksson HJ, Jónsson S, Thorsteinsson H, Gudbjartsson T.

Laeknabladid. 2010 Apr;96(4):251-7. Icelandic.

PMID:
20339164
17.

Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.

Koike T, Koike T, Yoshiya K, Tsuchida M, Toyabe S.

J Thorac Cardiovasc Surg. 2013 Aug;146(2):372-8. doi: 10.1016/j.jtcvs.2013.02.057.

18.

Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.

Wang CY, Huang MS, Huang MH, Lee HC, Hsu HS.

J Surg Res. 2010 Oct;163(2):e45-50. doi: 10.1016/j.jss.2010.04.039. Epub 2010 May 21.

PMID:
20638687
19.

The incidence of venous thromboembolism among patients with primary lung cancer.

Chew HK, Davies AM, Wun T, Harvey D, Zhou H, White RH.

J Thromb Haemost. 2008 Apr;6(4):601-8. doi: 10.1111/j.1538-7836.2008.02908.x. Epub 2008 Jan 17.

20.

Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.

Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N.

Eur J Cardiothorac Surg. 2007 Sep;32(3):435-9. Epub 2007 Jul 3.

PMID:
17611117

Supplemental Content

Support Center